US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% NVDA $233.95 ▲+0.00% SNDK $1,719.99 ▲+0.00% SPCX $158.96 ▲+0.00% SDEV $7.48 ▲+0.00% TSLA $370.59 ▲+0.00% AMD $633.91 ▲+0.00%
FinancialContent

Articles published by Chimerix, Inc.

News headline image
Chimerix Reports Fourth Quarter and Year End 2024 Financial Results
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Announces FDA Acceptance and Priority Review of New Drug Application for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix to Speak Today at The White House Cancer Moonshot Forum
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix to Present at H.C. Wainwright 26th Annual Global Investment Conference
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August 13, 2024
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Appoints Marc D. Kozin to Board of Directors
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX UFPT
News headline image
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix to Present at TD Cowen 44th Annual Health Care Conference
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Appoints Lisa Decker to Board of Directors
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX
News headline image
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Chimerix, Inc.
Via GlobeNewswire
Tickers CMRX